|
PTPLB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.76830003154549E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.54020004819955E-09 |
| Normal-vs-Stage2 |
3.208500E-04 |
| Normal-vs-Stage3 |
1.398990E-03 |
| Normal-vs-Stage4 |
4.358900E-04 |
| Stage1-vs-Stage2 |
3.737200E-01 |
| Stage1-vs-Stage3 |
2.433200E-01 |
| Stage1-vs-Stage4 |
8.599800E-01 |
| Stage2-vs-Stage3 |
9.025400E-01 |
| Stage2-vs-Stage4 |
6.765400E-01 |
| Stage3-vs-Stage4 |
6.383000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.45770001519696E-09 |
| Normal-vs-AfricanAmerican |
3.43269999980578E-07 |
| Normal-vs-Asian |
5.384400E-04 |
| Caucasian-vs-AfricanAmerican |
9.485800E-01 |
| Caucasian-vs-Asian |
6.947200E-01 |
| AfricanAmerican-vs-Asian |
6.646400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75182091055603E-12 |
| Normal-vs-Female |
9.975100E-03 |
| Male-vs-Female |
3.181600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.82159999995157E-06 |
| Normal-vs-Extreme_Weight |
4.71289673953379E-11 |
| Normal-vs-Obese |
1.73279999999831E-05 |
| Normal-vs-Extreme_Obese |
3.93650000000134E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.973550E-01 |
| Normal_Weight-vs-Obese |
5.312000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.644400E-01 |
| Extreme_Weight-vs-Obese |
2.263700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.870200E-01 |
| Obese-vs-Extreme_Obese |
3.796000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.395980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.81049999992133E-07 |
| Normal-vs-Age(61-80Yrs) |
2.2540969091267E-11 |
| Normal-vs-Age(81-100Yrs) |
7.40469999760407E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.979000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.807220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.430200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.680200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.976700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.144380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.1984968573131E-11 |
| Normal-VS-Type2 PRCC |
2.24889999955735E-08 |
| Normal-VS-KIRP CIMP |
7.161200E-01 |
| Normal-VS-Unclassified PRCC |
2.561200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.325000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.703800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.119240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.858300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.656400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.501500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.17694742840513E-12 |
| Normal-vs-N1 |
2.127700E-02 |
| Normal-vs-N2 |
2.941600E-02 |
| N0-vs-N1 |
2.049600E-02 |
| N0-vs-N2 |
6.676800E-01 |
| N1-vs-N2 |
6.253400E-01 |
|
|
